Kolon Life Science Inc. (KOSDAQ: 102940)

Kolon Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	229,087	293,298	312,699	493,057	331,408	205,918
Market Cap Growth	-31.85%	-6.20%	-36.58%	48.78%	60.94%	-50.81%
Enterprise Value	328,619	380,259	385,923	578,014	375,012	249,522
Last Close Price	18440.00	25700.00	27400.00	43250.00	29050.00	18050.00
PE Ratio	-	-9.55	162.13	-357.44	-7.67	-2.23
PS Ratio	1.50	2.35	1.94	2.98	2.56	1.39
PB Ratio	1.78	2.13	1.86	4.96	5.72	2.04
P/FCF Ratio	-5.95	-8.38	-11.51	-23.93	-32.97	-4.04
P/OCF Ratio	-7.91	-11.80	-14.99	-30.46	-45.35	-10.20
EV/Sales Ratio	2.34	3.05	2.39	3.49	2.90	1.68
EV/EBITDA Ratio	-22.85	-24.91	31.87	37.17	-29.28	-19.96
EV/EBIT Ratio	-14.74	-15.78	146.09	136.03	-14.52	-9.40
EV/FCF Ratio	-8.30	-10.86	-14.21	-28.06	-37.31	-4.90
Debt / Equity Ratio	0.98	0.78	0.44	0.69	1.33	0.78
Debt / EBITDA Ratio	-	-	6.10	4.43	-	-
Debt / FCF Ratio	-3.16	-3.08	-2.72	-3.35	-7.66	-1.55
Asset Turnover	0.41	0.40	0.59	0.69	0.49	-
Inventory Turnover	2.20	1.65	2.18	2.89	2.81	-
Quick Ratio	0.33	0.26	0.33	0.50	0.26	0.40
Current Ratio	0.62	0.82	1.01	1.03	0.69	0.72
Return on Equity (ROE)	-58.21%	-22.00%	3.01%	-1.75%	-54.34%	-
Return on Assets (ROA)	-4.33%	-4.83%	0.60%	1.10%	-6.13%	-
Return on Capital (ROIC)	-5.73%	-6.18%	0.81%	1.75%	-10.26%	-
Earnings Yield	-39.96%	-10.48%	0.68%	-0.28%	-13.03%	-44.84%
FCF Yield	-17.29%	-11.94%	-8.69%	-4.18%	-3.03%	-24.75%
Buyback Yield / Dilution	-0.46%	9.69%	-10.85%	-	0.01%	-22.77%
Total Shareholder Return	-0.46%	9.69%	-10.85%	-	0.01%	-22.77%

Source: S&P Capital IQ. Standard template. Financial Sources.